Paolo Manca
Milan, Italy
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 51 publications
Predictive biomarkers for cetuximab-based rechallenge therapy in metastatic colorectal cancer: a pooled analysis of the CAVE and CAVE-2 GOIM studies.
Journal: ESMO gastrointestinal oncology
Published: August 28, 2026
Toxicity-over-time analysis of anti-EGFR-based maintenance versus stop&go in left-sided, RAS/BRAF wild-type metastatic colorectal cancer.
Journal: Journal of the National Cancer Institute
Published: February 19, 2026
Association of ctDNA RAS mutational status and clinical benefits in first-line metastatic colorectal cancer therapy with chemotherapy plus anti-EGFR (overall response rate and progression-free survival): a brief report of systematic review and meta-analysis.
Journal: Journal of gastrointestinal oncology
Published: February 09, 2026
Anti-EGFR-based maintenance versus stop and go in patients with left-sided, non-MSI-H, RAS/BRAF-wt metastatic colorectal cancer: individual patient data pooled analysis.
Journal: ESMO open
Published: January 16, 2026
Molecular Lineages of Sporadic Mismatch Repair-Deficient Colorectal Cancer.
Journal: Clinical cancer research : an official journal of the American Association for Cancer Research
Published: January 03, 2026
Cetuximab rechallenge in molecularly selected metastatic colorectal cancer: the randomized CAVE-2 GOIM trial.
Journal: Annals of oncology : official journal of the European Society for Medical Oncology
Published: November 04, 2025
Neoadjuvant CTLA-4/PD-(L)1 Blockade Versus Surgery +/- Chemotherapy in Deficient Mismatch Repair/Microsatellite Instability-High Resectable Gastroesophageal Adenocarcinoma: Individual Patient Data Pooled Analysis.
Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology
Published: September 29, 2025
Re-treatment with panitumumab followed by regorafenib versus the reverse sequence in chemorefractory metastatic colorectal cancer patients with RAS and BRAF wild-type circulating tumor DNA: the PARERE study by GONO.
Journal: Annals of oncology : official journal of the European Society for Medical Oncology
Published: September 05, 2025
Genomics correlates of brain metastasis and progression in colorectal cancer.
Journal: Neuro-oncology
Published: September 02, 2025
ctDNA Detection with Low-Pass Whole-Genome Bisulfite Sequencing in RAS Wild-Type Metastatic Colorectal Cancer: An Exploratory Objective of the VALENTINO Trial.
Journal: Clinical cancer research : an official journal of the American Association for Cancer Research
Published: July 25, 2025
Ultrasensitive ctDNA monitoring for organ preservation in patients with locally advanced rectal cancer.
Journal: NPJ precision oncology
Published: May 29, 2025
Last Updated: 09/26/2026